This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

13 ASCO Stocks Presenting New Clinical Data

Pharmacyclics (PCYC - Get Report)

Drug: PCI-32765

Abstract No. 8012

Indication: non-Hodgkin's lymphoma

Clinical Trial: Btk inhibitor PCI-32765 monotherapy induces objective responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study.

Presentation Time: Saturday, June 5. Oral session.

Notes: Interim data from 19 of 22 patients are reported in Thursday night's ASCO abstract, with a 42% overall response rate. This includes 1 patient reporting a complete response and 7 patients with partial responses. All patients in the study were diagnosed with advanced NHL, previously treated with a median of three therapies. Phase II studies of PCI-32765 are planned.

Since December, Pharmacyclics shares have gone from $2 to $7 as the company puts a history of drug development failures behind it and builds a new research pipeline.

5 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
ZIOP $9.75 2.40%
ARQL $2.07 -0.96%
CLDX $25.15 1.70%
CRIS $2.69 2.30%
NKTR $11.33 -1.30%


DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs